OREANDA-NEWS. SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN, OTCPK: SMDCY) (“SHL”), a leading provider and developer of advanced personal telemedicine solutions, announced today that Mr. Xuewen Wu was unanimously elected by the Board to serve as SHL’s Chairman of the Board of Directors. For resume of Mr. Wu please refer to SHL’s website at www.shl-telemedicine.com.

The Board has thanked the former Chairman, Mr. Elon Shalev, for his committed service as Chairman and has congratulated Mr. Wu on his nomination.

Mr. Wu said: “I am honoured to accept the challenge of leading the Board and work in collaboration with SHL’s excellent and dedicated management and employees to lead SHL to growth and success.”

 

About SHL Telemedicine

SHL Telemedicine is engaged in developing and marketing personal telemedicine systems and the provision of medical call center services, with a focus on cardiovascular and related diseases, to end users and to the healthcare community. SHL Telemedicine offers its services and personal telemedicine devices to subscribers utilizing telephonic and Internet communication technology. SHL is listed on the SIX Swiss Exchange (SHLTN, ISIN: IL0010855885, Security No.: 1128957) and has an ADR program listed over-the counter; Symbol: SMDCY.